Location: Home
  • search
  • go
  • Relate News
  • 4/27/2023CDE Issues the Technical Guidelines for Clinical Trials of Chronic Hep...
  • 4/27/2023Southeast Asia Is Becoming a Hot New Market for China's Innovative Dru...
  • 4/26/2023Why Rising Demand for Healthcare Is Creating Investment Opportunities ...
  • 4/26/2023CFDI Issues the Dossier Requirements for GLP Certification of Drug Non...
  • 4/26/2023CFDI Solicits Public Comments on the Inspection Points and Judgment Pr...
  • 4/26/2023CDE Solicits Comments on Draft Implementation Suggestions of ICH Guide...
  • 4/26/2023CDE Issues the Technical Guidelines for Clinical Trials of Active Immu...
  • 4/26/2023Fosun Reportedly Drops Plan to Sell Stake in Gland Pharma
  • 4/25/2023I-Mab Announces Positive Outcome in Arbitration Relating to Agreements...
  • 4/25/2023NMPA Announces Package Insert Revision of Additional Two Drug Products
  • 4/25/2023NMPA Issues the Opinions for Improving Review and Approval of Radiopha...
  • 4/25/2023Xinhua: Centralized VBP Led to 48% Average Insulin Price Cut and Annua...
  • 4/25/2023Sable Thera and Liuqiang MedTech Enter Licensing Deal for Fat Reducing...
  • 4/25/2023Drug Licensing as Evidence of Evolution, Diffusion and Catch-up in Eas...
  • 4/25/2023Despite Strong Year-on-Year Growth in Q1, Licensing Deals Slow in Marc...
  • 4/24/2023Grand Pharma Buys BlackSwan Vascular For $37.5 Million
  • 4/24/2023NMPA Issues Announcement for Applicability of ICH Guidelines E19
  • 4/24/2023NMPA Announces Package Insert Revision of Multiple Drug Products
  • 4/21/2023NMPA Issues the 2022 Drug Regulatory Statistics Annual Report
  • 4/21/2023PhIIC: Review of Chinese Rep Hospital Drug Market in 2022
  • 4/21/2023Drug R&D and Product Registration News Digest April 2023 (3)
  • 4/21/2023AstraZeneca Oncology R&D Head On China Biotech Innovation - Looking Ag...
  • 4/20/2023As Competition Heats Up, China PD-(L)1 Inhibitors Seek More Differenti...
  • 4/20/2023The US Is Relying More on China for Pharmaceuticals — and Vice Versa ...
  • 4/20/2023Gene Editing: China's New Regulations Contain Concerning Loopholes, Ex...
  • 4/19/2023Investors See Confidence in China Slowly Back In 2023; Seeking China-J...
  • 4/19/2023What A US-China Biotech War Would Mean for Hong Kong and the World (SC...
  • 4/19/2023How Can Phase I Data from Western Medicine Accelerate Drug Development...
  • 4/19/2023Everest Medicines Enters Strategic Partnership with Shanghai Pharma Su...
  • 4/19/2023Crystal Pharmatech's CDMO BU Receives China Drug Product Manufacturing...
  • Page:128/798 Total number of articles:23926: [First][<<] [126] [127] [128] [129] [130] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group